REQUEST A DEMO
Total
USD $0.00
Search more companies

Zentiva k.s. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmaceutical and Medicine Manufacturing
Full name: Zentiva k.s. Profile Updated: September 12, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2017 Available in: English Download a sample report

Zentiva is a pharmaceutical group, specialized in the development, manufacturing and marketing of branded equivalents. It holds the leading positions in the Czech and Slovak markets and is among the pharmaceutical players within the Central and Eastern European (CEE) region. The Czech Republic, the Slovak Republic, Poland and the Russian Federation are currently the most important markets for the Zentiva group. The company is also developing its business in many other countries in Central and Eastern Europe. The company´s product range consists of almost 270 products in some 500 pharmaceutical presentations. While Zentiva addresses a large number of therapeutic areas, it focuses, in particular, on the treatment of cardiovascular disorders, inflammatory conditions, pain, infections and diseases of the central nervous system and the gastrointestinal and urinary tracts. It also has a growing consumer healthcare portfolio comprising over-the-counter (OTC) medicines and dietary supplements.

Headquarters
Dolni Mecholupy, U kabelovny 130
Prague; The City of Prague; Postal Code: 10237

Contact Details: Purchase the Zentiva k.s. report to view the information.

Website: http://www.zentiva.cz

Basic Information
Total Employees:
Purchase the Zentiva k.s. report to view the information.
Outstanding Shares:
Purchase the Zentiva k.s. report to view the information.
Registered Capital:
Purchase the Zentiva k.s. report to view the information.
Financial Auditors:
Purchase the Zentiva k.s. report to view the information.
Ratings:
Purchase the Zentiva k.s. report to view the information.
Incorporation Date:
April 01, 1993
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Subsidiaries
Company Performance
Financial values in the chart are available after Zentiva k.s. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-3.5%
Total operating revenue
-2.19%
Operating profit (EBIT)
14.69%
EBITDA
9.29%
Net Profit (Loss) for the Period
12.14%
Total assets
3%
Total equity
0.67%
Operating Profit Margin (ROS)
3.72%
Net Profit Margin
0.66%
Return on Equity (ROE)
0.63%
Debt to Equity Ratio
0.32%
Quick Ratio
0.4%
Cash Ratio
-0%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?